"At Cancer Care Associates of York, we strive to provide our community with innovative, comprehensive and compassionate care which respects the values and needs of each individual diagnosed with cancer or blood disorders."

During the past decade, Cancer Care Associates of York conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 3 clinical trials were completed, i.e. on average, 13% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 3 clinical trials were completed. i.e. 18.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cancer Care Associates of York" #1 sponsor was "National Cancer Institute (NCI)" with 8 trials, followed by "Celgene" with 3 trials sponsored, "Alliance for Clinical Trials in Oncology" with 2 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 2 trials sponsored and "Tempus Labs" with 2 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cancer Care Associates of York" #1 collaborator was "National Cancer Institute (NCI)" with 5 trials as a collaborator, "Amalgam Rx" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Cancer Care Associates of York" are "Stage IIIB Lung Cancer AJCC v8" (4 trials), "Stage IV Lung Cancer AJCC v8" (4 trials), "Breast Cancer" (2 trials), "Lung Non-Squamous Non-Small Cell Carcinoma" (2 trials) and "Lymphoma" (2 trials). Many other conditions were trialed in "Cancer Care Associates of York" in a lesser frequency.

Most popular intervention types in "Cancer Care Associates of York" are "Drug" (17 trials), "Other" (10 trials), "Biological" (9 trials), "Procedure" (9 trials) and "Dietary Supplement" (2 trials). Other intervention types were less common.

The name of intervention was led by "Biospecimen Collection" (7 trials), "Computed Tomography" (7 trials), "Magnetic Resonance Imaging" (5 trials), "Atezolizumab" (4 trials) and "Paclitaxel" (4 trials). Other intervention names were less common.

The vast majority of trials in "Cancer Care Associates of York" are 24 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Cancer Care Associates of York". undefined are not yet recruiting, 16 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Cancer Care Associates of York, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Cancer Care Associates of York, 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".